At FDA's request, Type D Meeting expected in March 2026 to review Comparative Oncology biomarker data from patients treated in OST-HER2 Phase 2b human clinical trial and OST-HER2 trial in spontaneous ...
Beat Saber will receive OST 8 next month, marking the first OST release in over a year. As a reminder, these Beat Saber tracks won't be available on either PlayStation VR or PlayStation VR2. Meta ...
OS Therapies on track to complete clinical data submission by the end of Q1 2026 New York, New York--(Newsfile Corp. - March 9, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the ...
Interim analysis data show improvements in overall survival with OST-HER2 in this osteosarcoma population compared with historical controls. Treatment with the investigational HER2-directed ...
ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage oncology-focused immunotherapy company developing cancer vaccines and antibody drug conjugate (ADC) therapeutic ...
NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced ...
A total of 35% of patients with fully resected metastatic lung osteosarcoma treated with OST-HER2 achieved 1-year event-free survival. Safety data from the trial revealed that 13 patients experienced ...
Former Beat Games CEO and current Head of Music revealed late last year during a video livestream (more details here) that the “theme” for OST 4 will be “guitars and synthetic guitars” with “metal-ish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results